Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Catalyst Pharmaceutical Partners Inc buy Truist Financial Co.

Catalyst Pharmaceutical Partners Inc
Start price
€22.00
11.11.24 / 50%
Target price
€33.80
11.11.25
Performance (%)
-10.57%
End price
€19.68
12.11.25
Summary
This prediction ended on 12.11.25 with a price of €19.68. The prediction for Catalyst Pharmaceutical Partners Inc disappointed with a performance of -10.57%. Truist_Financial_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Catalyst Pharmaceutical Partners Inc -0.396% -0.396% -1.324%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Truist_Financial_Co_ for this prediction

In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Prediction Buy
Perf. (%) -10.57%
Target price 33.797
Change
Ends at 11.11.25

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Truist Financial Co. from $30.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat

Truist Financial Co. 
0
Report Share
11.11.24
In the thread Trading Catalyst Pharmaceutical Partners Inc
Prediction Buy
Perf. (%) -10.57%
Target price 33.797
Change
Ends at 11.11.25

Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten

Truist Financial Co. 
0
Report Share
12.11.25

Stopped prediction by Truist_Financial_Co_ for Catalyst Pharmaceutical Partners Inc

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€16.68
09.08.24
€27.48
09.08.25
1.02%
10.08.25

Truist Financial Co. 
09.08.24 50%